Accessibility and reading comfort

Text size

Light/Dark mode

Lines vertical spacing

Trouble using our website?
Contact us

GENPHENACL

In this page

Clinical Trial

NCT02970266 Completed
GENPHENACL

Genetic Decryption of Leber Congenital Amaurosis (LCA) in a Large Cohort of Independent Families.

Observational
Observational

Disease

Disease type

Leber Congenital Amaurosis

Orphan drug recognition

NA

Patient type

Adult

Children

Inclusion / Exclusion

Opening date

01/09/2010

Closing date

01/11/2016

Inclusion criteria :

More

Exclusion criteria :

More

Funding

public

Members involved

Others investigators

Pr Dominique BREMOND-GIGNAC

Representative

France

Anterior Segment Rare Eye Diseases (WG4), CPMS & Digital Medecine (TWG10), Genetic Diagnostics (TWG6), Low Vision Daily Life and Patients Groups (TWG5), National Integration (TWG9), Neuro-Ophthalmology Rare Diseases (WG2), Pediatric Ophthalmology Rare Diseases (WG3), Registries & Epidemiology (TWG7), Research (TWG8), Retinal Rare Eye Diseases (WG1)
Working Group Leader
See more

ERN EYE member investigating site

HCP : Principal investigators

OPHTARA – AP-HP, Hôpital Necker-Enfants Malades, Paris, France

Adress

Service d'ophtalmologieBât. Lecourbe - RC149 rue de Sèvres

75 015 Paris

France